126 related articles for article (PubMed ID: 34414945)
1. LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA).
Jin TY; Saindane M; Park KS; Kim S; Nam S; Yoo Y; Yang JH; Yun I
Medicine (Baltimore); 2021 Aug; 100(33):e26896. PubMed ID: 34414945
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M; Chen H; Wang M; Bai F; Wu K
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
[TBL] [Abstract][Full Text] [Related]
4. Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
Gan S; Dai H; Li R; Liu W; Ye R; Ha Y; Di X; Hu W; Zhang Z; Sun Y
Gland Surg; 2020 Jun; 9(3):661-675. PubMed ID: 32775256
[TBL] [Abstract][Full Text] [Related]
5. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
Liu R; Guo CX; Zhou HH
Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Prostaglandin-Endoperoxide Synthase-2 Expressions in Human Breast Carcinoma: A Multiomic Approach.
Saindane M; Rallabandi HR; Park KS; Heil A; Nam SE; Yoo YB; Yang JH; Yun IJ
Cancer Inform; 2020; 19():1176935120969696. PubMed ID: 33223820
[TBL] [Abstract][Full Text] [Related]
7. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis revealing prognostic significance of
Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
[No Abstract] [Full Text] [Related]
9.
Jin TY; Park KS; Nam SE; Yoo YB; Park WS; Yun IJ
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409110
[TBL] [Abstract][Full Text] [Related]
10. Cell division cycle proteinising prognostic biomarker of breast cancer.
Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer.
Wang Q; Zhao S; Gan L; Zhuang Z
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830857
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HMGB3 and its prognostic value in breast cancer.
Zhou X; Zhang Q; Liang G; Liang X; Luo B
Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer.
Zhang Y; Gao Y; Li Y; Zhang X; Xie H
Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715
[TBL] [Abstract][Full Text] [Related]
14. In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkers.
Kim J
World J Surg Oncol; 2021 Jun; 19(1):188. PubMed ID: 34172056
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
[TBL] [Abstract][Full Text] [Related]
16. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor (
Nam SE; Jin T; Park KS; Saindane M; Noh WC; Yoo YB; Park WS; Yun IJ
Ann Surg Treat Res; 2022 Oct; 103(4):183-194. PubMed ID: 36304189
[TBL] [Abstract][Full Text] [Related]
18. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
Yu Z; Cheng L; Liu X; Zhang L; Cao H
Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
[No Abstract] [Full Text] [Related]
20. LEP (-2548G>A LEP) and LEPR (223Gln>Arg, 109Lys>Arg) polymorphisms as breast cancer risk factors in the Polish female population.
Hołysz H; Paszel-Jaworska A; Romaniuk-Drapała A; Grodecka-Gazdecka S; Rubiś B
Mol Biol Rep; 2021 Apr; 48(4):3237-3244. PubMed ID: 33864589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]